Argitalpenak (58) IRENE COZAR CASTELLANO argitalpenak

2024

  1. Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation (Diabetologia, (2022), 65, 8, (1375-1389), 10.1007/s00125-022-05729-y)

    Diabetologia

2023

  1. Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging

    Journal of Neuroinflammation, Vol. 20, Núm. 1

  2. Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice

    Diabetes, Obesity and Metabolism, Vol. 25, Núm. 11, pp. 3268-3278

2022

  1. Evolutionary Origin of Insulin-Degrading Enzyme and Its Subcellular Localization and Secretion Mechanism: A Study in Microglial Cells

    Cells, Vol. 11, Núm. 2

  2. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation

    Diabetologia, Vol. 65, Núm. 8, pp. 1375-1389

  3. Primary Cilia in Pancreatic β- and α-Cells: Time to Revisit the Role of Insulin-Degrading Enzyme

    Frontiers in Endocrinology, Vol. 13

2021

  1. Effects of fasting and feeding on transcriptional and posttranscriptional regulation of insulin‐degrading enzyme in mice

    Cells, Vol. 10, Núm. 9

  2. Fisiología del sistema endocrino: manual del estudiante

    Ediciones Universidad de Valladolid (EdUVa)

  3. Modulation of insulin sensitivity by insulin-degrading enzyme

    Biomedicines, Vol. 9, Núm. 1, pp. 1-38

  4. Retraction notice: Retraction notice to “Growth factors and beta cell replication” (International Journal of Biochemistry and Cell Biology (2007) 39(11) (2049–2062), (S1357272507001768), (10.1016/j.biocel.2007.05.023))

    International Journal of Biochemistry and Cell Biology

  5. miR-126 contributes to the epigenetic signature of diabetic vascular smooth muscle and enhances antirestenosis effects of Kv1.3 blockers

    Molecular Metabolism, Vol. 53

2020

  1. Assessment of Insulin Tolerance Ex Vivo

    Methods in molecular biology (Clifton, N.J.), Vol. 2128, pp. 291-300

  2. Assessment of Insulin Tolerance In Vivo in Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2128, pp. 217-224

  3. Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice

    Metabolism: Clinical and Experimental, Vol. 113

  4. Intestinal fructose and glucose metabolism in health and disease

    Nutrients, Vol. 12, Núm. 1

  5. Modulation of Glial Responses by Furanocembranolides: Leptolide Diminishes Microglial Inflammation in Vitro and Ameliorates Gliosis In Vivo in a Mouse Model of Obesity and Insulin Resistance

    Marine drugs, Vol. 18, Núm. 8

2019

  1. Manipulation of Transmembrane Transport by Synthetic K+ Ionophore Depsipeptides and Its Implications in Glucose-Stimulated Insulin Secretion in β-Cells

    Chemistry - A European Journal, Vol. 25, Núm. 39, pp. 9287-9294

  2. Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity

    American journal of physiology. Endocrinology and metabolism, Vol. 317, Núm. 5, pp. E805-E819

2018

  1. Cembranoids from Eunicea sp. enhance insulin-producing cells proliferation

    Tetrahedron, Vol. 74, Núm. 16, pp. 2056-2062

  2. Chloro-furanocembranolides from Leptogorgia sp. Improve pancreatic beta-cell proliferation

    Marine Drugs, Vol. 16, Núm. 2